Toru Kanke

4.2k total citations · 2 hit papers
35 papers, 3.2k citations indexed

About

Toru Kanke is a scholar working on Hematology, Genetics and Cancer Research. According to data from OpenAlex, Toru Kanke has authored 35 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 13 papers in Genetics and 11 papers in Cancer Research. Recurrent topics in Toru Kanke's work include Blood Coagulation and Thrombosis Mechanisms (17 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers) and Protease and Inhibitor Mechanisms (8 papers). Toru Kanke is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (17 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers) and Protease and Inhibitor Mechanisms (8 papers). Toru Kanke collaborates with scholars based in Japan, United Kingdom and China. Toru Kanke's co-authors include Robin Plevin, Scott R. Macfarlane, Michael J. Seatter, Gary D. Hunter, G. D. Hunter, J. Kawagoe, Masahiro Nishibori, Hideo Takahashi, Andrew J. H. Smith and Stephen Meek and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Toru Kanke

33 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Proteinase-activated Receptors

2006 696 citations Scott R. Macfarlane, Michael J. Seatter et al. PubMed profile →
Proteinase-Activated Receptors

2001 564 citations Scott R. Macfarlane, Michael J. Seatter et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toru Kanke Japan	25	1.6k	853	760	602	552	35	3.2k
Bahjat Al‐Ani Saudi Arabia	30	1.4k 0.9×	1.1k 1.3×	816 1.1×	498 0.8×	646 1.2×	94	3.4k
Eric Camerer United States	32	2.3k 1.4×	928 1.1×	1.9k 2.5×	537 0.9×	864 1.6×	53	5.1k
Mahmoud Saifeddine Canada	34	2.0k 1.2×	1.5k 1.7×	739 1.0×	592 1.0×	512 0.9×	66	3.2k
Nicole C. Kaneider Austria	36	905 0.6×	256 0.3×	1.1k 1.4×	393 0.7×	730 1.3×	62	3.2k
Tetsuhito Kojima Japan	39	1.6k 1.0×	412 0.5×	1.9k 2.5×	517 0.9×	472 0.9×	193	4.6k
Anna M. Randi United Kingdom	40	933 0.6×	329 0.4×	2.2k 2.9×	557 0.9×	848 1.5×	100	4.9k
Alastair W. Poole United Kingdom	39	2.4k 1.5×	498 0.6×	1.8k 2.3×	245 0.4×	800 1.4×	112	5.2k
Kewal Asosingh United States	43	1.1k 0.7×	322 0.4×	1.9k 2.4×	578 1.0×	617 1.1×	118	4.4k
Bruce A. Hug United States	23	601 0.4×	334 0.4×	1.6k 2.0×	291 0.5×	590 1.1×	47	3.6k
Wadie F. Bahou United States	36	1.5k 0.9×	529 0.6×	1.5k 2.0×	1.2k 2.0×	430 0.8×	95	4.3k

Countries citing papers authored by Toru Kanke

Since Specialization

Citations

This map shows the geographic impact of Toru Kanke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru Kanke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru Kanke more than expected).

Fields of papers citing papers by Toru Kanke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toru Kanke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru Kanke. The network helps show where Toru Kanke may publish in the future.

Co-authorship network of co-authors of Toru Kanke

This figure shows the co-authorship network connecting the top 25 collaborators of Toru Kanke. A scholar is included among the top collaborators of Toru Kanke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toru Kanke. Toru Kanke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goh, Fui G., et al.. (2009). Dual effect of the novel peptide antagonist K‐14585 on proteinase‐activated receptor‐2‐mediated signalling. British Journal of Pharmacology. 158(7). 1695–1704. 38 indexed citations

Kanke, Toru, Satoko Kubo, Shinichi Kondo, et al.. (2009). Novel antagonists for proteinase‐activated receptor 2: inhibition of cellular and vascular responsesin vitroandin vivo. British Journal of Pharmacology. 158(1). 361–371. 42 indexed citations

Takahashi, Hideo, Hiromi Iwagaki, Toru Kanke, et al.. (2008). STIMULATION OF ADENOSINE A2A RECEPTOR INHIBITS LPS-INDUCED EXPRESSION OF INTERCELLULAR ADHESION MOLECULE 1 AND PRODUCTION OF TNF-α IN HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS. Shock. 29(2). 154–159. 17 indexed citations

Saka, Masako, Christopher MacKenzie, Robert J. Drummond, et al.. (2007). Cytokine upregulation of proteinase‐activated‐receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinaseβin human endothelial cells. British Journal of Pharmacology. 150(8). 1044–1054. 69 indexed citations

Takahashi, Hideo, Toru Kanke, Keyue Liu, et al.. (2007). Adenosine A2A-Receptor Stimulation Inhibits Lipopolysaccharide-Induced Interleukin-18 Production in Monocytes. Journal of Pharmacological Sciences. 104(2). 183–186. 9 indexed citations

Takahashi, Hideo, Hiromi Iwagaki, Hidenori Wake, et al.. (2007). Effects of adenosine on adhesion molecule expression and cytokine production in human PBMC depend on the receptor subtype activated. British Journal of Pharmacology. 150(6). 816–822. 29 indexed citations

Takahashi, Hideo, Hiromi Iwagaki, Toru Kanke, et al.. (2007). Effect of adenosine receptor subtypes stimulation on mixed lymphocyte reaction. European Journal of Pharmacology. 564(1-3). 204–210. 20 indexed citations

Macfarlane, Scott R., Michael J. Seatter, Toru Kanke, G. D. Hunter, & Robin Plevin. (2006). Proteinase-activated Receptors. PubMed. 53(2). 762–766. 696 indexed citations breakdown →

Kawabata, Atsufumi, Maho Matsunami, Masahiro Tsutsumi, et al.. (2006). Suppression of pancreatitis‐related allodynia/hyperalgesia by proteinase‐activated receptor‐2 in mice. British Journal of Pharmacology. 148(1). 54–60. 44 indexed citations

10.

Kawabata, Atsufumi, Naoyuki Kawao, Tomoko Kitano, et al.. (2006). Colonic hyperalgesia triggered by proteinase-activated receptor-2 in mice: Involvement of endogenous bradykinin. Neuroscience Letters. 402(1-2). 167–172. 22 indexed citations

11.

Takahashi, Hideo, Hiromi Iwagaki, Toru Kanke, et al.. (2006). The immunosuppressive effects of nicotine during human mixed lymphocyte reaction. European Journal of Pharmacology. 559(1). 69–74. 25 indexed citations

12.

Macfarlane, Scott R., Callum M. Sloss, Pamela Cameron, et al.. (2005). The role of intracellular Ca²⁺ in the regulation of proteinase‐activated receptor‐2 mediated nuclear factor kappa B signalling in keratinocytes. British Journal of Pharmacology. 145(4). 535–544. 51 indexed citations

13.

Kanke, Toru, et al.. (2005). Physiology and Pathophysiology of Proteinase-Activated Receptors (PARs): PAR-2 as a Potential Therapeutic Target. Journal of Pharmacological Sciences. 97(1). 38–42. 37 indexed citations

14.

Kanke, Toru, Hiroyuki Ishiwata, Masako Saka, et al.. (2005). Binding of a highly potent protease‐activated receptor‐2 (PAR2) activating peptide, [³H]2‐furoyl‐LIGRL‐NH₂, to human PAR2. British Journal of Pharmacology. 145(2). 255–263. 27 indexed citations

15.

Kawabata, Atsufumi, Toru Kanke, Tsuyoshi Ishiki, et al.. (2004). Potent and Metabolically Stable Agonists for Protease-Activated Receptor-2: Evaluation of Activity in Multiple Assay Systems in Vitro and in Vivo. Journal of Pharmacology and Experimental Therapeutics. 309(3). 1098–1107. 59 indexed citations

16.

Kawabata, Atsufumi, Satoko Kubo, Tsuyoshi Ishiki, et al.. (2004). Proteinase-Activated Receptor-2-Mediated Relaxation in Mouse Tracheal and Bronchial Smooth Muscle: Signal Transduction Mechanisms and Distinct Agonist Sensitivity. Journal of Pharmacology and Experimental Therapeutics. 311(1). 402–410. 33 indexed citations

17.

Ferrell, William R., John C. Lockhart, Elizabeth B. Kelso, et al.. (2003). Essential role for proteinase-activated receptor-2 in arthritis. Journal of Clinical Investigation. 111(1). 35–41. 239 indexed citations

18.

Seatter, Michael J., Robert M. Drummond, Toru Kanke, et al.. (2003). The role of the C-terminal tail in protease-activated receptor-2-mediated Ca2+ signalling, proline-rich tyrosine kinase-2 activation, and mitogen-activated protein kinase activity. Cellular Signalling. 16(1). 21–29. 34 indexed citations

19.

Morikawa, Shigeru, Wakako Takabe, Chikage Mataki, et al.. (2002). The Effect of Statins on mRNA Levels of Genes Related to Inflammation, Coagulation, and Vascular Constriction in HUVEC.. Journal of Atherosclerosis and Thrombosis. 9(4). 178–183. 140 indexed citations

20.

Kanke, Toru, Scott R. Macfarlane, Michael J. Seatter, et al.. (2001). Proteinase-activated Receptor-2-mediated Activation of Stress-activated Protein Kinases and Inhibitory κB Kinases in NCTC 2544 Keratinocytes. Journal of Biological Chemistry. 276(34). 31657–31666. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact